Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Luke Hillman"'
Autor:
Sean G. Kelly, Toby C. Campbell, Luke Hillman, Adnan Said, Michael R. Lucey, Parul D. Agarwal
Publikováno v:
Annals of Hepatology, Vol 16, Iss 3, Pp 395-401 (2017)
Introduction and Aim: Utilization of palliative care services in patients dying of end-stage liver disease (ESLD) is understudied. We performed a retrospective review of palliative care services among patients with ESLD unsuitable for liver transplan
Externí odkaz:
https://doaj.org/article/08aa1b57b91343cca0360e57452ac937
Autor:
Luke Hillman
Publikováno v:
Dune and Philosophy. :173-178
Publikováno v:
Diseases of the Esophagus. 36
Summary Many patients who experience esophageal food impaction (EFI) will have non-endoscopic resolution (NER) of their EFI, but this population is poorly defined. The purpose of this study is to describe the outcomes of patients with NER of EFI. A r
Autor:
Sarah Donohue, Luis D. Lomeli, Luke Hillman, Patrick Hoversten, Eric A. Gaumnitz, Aimee Teo Broman
Publikováno v:
Diseases of the Esophagus. 34
SummaryEsophageal food impaction (EFI) is often the first presentation for patients with eosinophilic esophagitis (EoE); however, there is significant heterogeneity in the management of EFI. We aimed to study the impact of EFI management, particularl
Publikováno v:
Gastroenterology. 162:S-540
Autor:
Lauren B. Gerson, Peter J. Kahrilas, John E. Pandolfino, David A. Katzka, Luke Hillman, Rena Yadlapati, Marcelo F. Vela, Ronnie Fass, Jenna Craft, Donald O. Castell, Philip O. Katz, Joel E. Richter, C. Prakash Gyawali, Stuart J. Spechler, Michael F. Vaezi, Nicholas J. Shaheen, Brian E. Lacy
Publikováno v:
American Journal of Gastroenterology. 113:980-986
BACKGROUND: The aim of this study was to assess expert gastroenterologists’ opinion on treatment for distinct gastroesophageal reflux disease (GERD) profiles characterized by proton pump inhibitor (PPI) unresponsive symptoms. METHODS: Fourteen esop
Publikováno v:
Gastroenterology. 160:S-255
Publikováno v:
Diseases of the Esophagus. 30:1-15
Up to 40% of patients report persistent gastroesophageal reflux disease (GERD) symptoms despite proton pump inhibitor (PPI) therapy. This review outlines the evidence for medical therapy for PPI nonresponsive GERD. A literature search for GERD therap
Autor:
M. Whitsett, Rena Yadlapati, Luke Hillman, A. J. Thuluvath, John E. Pandolfino, Mark A Berendsen
Publikováno v:
Diseases of the Esophagus. 30:1-14
Up to 40% of patients with gastroesophageal reflux disease (GERD) report persistent symptoms despite proton pump inhibitor (PPI) therapy. This review outlines the evidence for surgical and endoscopic therapies for the treatment of PPI nonresponsive G
Autor:
Abigail R. Sharpe, Sumona Saha, Freddy Caldera, Arnold Wald, Mary S. Hayney, Ian Grimes, Youqi Zhang, Luke Hillman, Mark Reichelderfer
Publikováno v:
Inflammatory bowel diseases. 26(4)
BackgroundPatients with inflammatory bowel disease (IBD) on anti-tumor necrosis factor alpha (TNF) agents may have lower immune response to the influenza vaccine. We aimed to evaluate the immunogenicity of the high dose (HD) vs standard dose (SD) inf